{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T08:14:07Z","timestamp":1773389647616,"version":"3.50.1"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Situs inversus totalis (SIT) is a rare congenital anomaly. Its co-occurrence with multiple primary malignancies is exceedingly uncommon. Low-grade myofibroblastic sarcoma (LGMS) and small cell lung cancer (SCLC) represent two distinct neoplasms with markedly different biological behaviors and treatment sensitivities. To our knowledge, the synchronous presentation of LGMS and SCLC in a patient with SIT has not been previously described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 72-year-old man with known SIT presented with respiratory symptoms. Imaging revealed a left hilar mass causing obstructive atelectasis, along\u00a0with metastatic lymphadenopathy in cervical and inguinal regions. Pathological assessment confirmed synchronous extensive-stage SCLC (ES-SCLC) and cervical\u00a0LGMS. Given the high chemosensitivity of SCLC, a sequential treatment strategy was implemented. The patient first received two cycles of induction chemoimmunotherapy with etoposide\/cisplatin plus tislelizumab, which resulted in resolution of metastatic lymph nodes. This was followed by surgical resection of the residual cervical LGMS and four cycles of consolidation chemoimmunotherapy. Subsequent management included sequential thoracic radiotherapy and maintenance immunotherapy with tislelizumab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This report presents the first documented case of synchronous LGMS and SCLC in a patient with SIT. Our experience suggests that a biology-driven sequential approach, prioritizing systemic therapy for chemosensitive SCLC followed by local control of LGMS, can achieve a initial favorable response. It also underscores that radiotherapy remains feasible in SIT following detailed anatomical evaluation. This case offers a clinically applicable, biology-guided sequential strategy for managing synchronous malignancies with divergent treatment sensitivities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1782502","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:26:29Z","timestamp":1773379589000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Synchronous low-grade myofibroblastic sarcoma and small cell lung cancer in a patient with situs inversus totalis: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"JiaJin","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Oncology, Fengcheng People\u2019s Hospital, Yichun University","place":["Yichun, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PeiLi","family":"Xiong","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Fengcheng People\u2019s Hospital, Yichun University","place":["Yichun, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoMeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Fengcheng People\u2019s Hospital, Yichun University","place":["Yichun, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoLin","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, Fengcheng People\u2019s Hospital, Yichun Universityi","place":["Yichun, Jiangx, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HuiLan","family":"Kuang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Ganzhou Cancer Hospital","place":["Ganzhou, Jiangxi, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S295444","article-title":"Situs inversus totalis: A clinical review","volume":"15","author":"Eitler","year":"2022","journal-title":"Int J Gen Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1186\/s13019-024-03098-8","article-title":"Uniportal left middle lobectomy in a patient with situs inversus totalis: a case report","volume":"19","author":"Jia","year":"2024","journal-title":"J Cardiothorac Surg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.14309\/crj.0000000000000483","article-title":"Performing endoscopic retrograde cholagiopancreatpgraphy and endoscopic ultrasound for management of Malignant bile duct obstruction in a patient with a situs inversus totalis","volume":"7","author":"Coronel","year":"2020","journal-title":"ACG Case Rep J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2005.12.003","article-title":"Human laterality disorders","volume":"49","author":"Peeters","year":"2006","journal-title":"Eur J Med Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1220743659","DOI":"10.1177\/0300060520944107","article-title":"Two types of lung cancer with situs inversus totalis: a case report and review of the literature","volume":"48","author":"Chen","year":"2020","journal-title":"J Int Med Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2024.07.263","article-title":"Situs inversus totalis with lung cancer: A case report","volume":"47","author":"Hou","year":"2024","journal-title":"Asian J Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s12672-025-03103-z","article-title":"Simultaneous medullary thyroid carcinoma and primary non-small cell lung cancer: case report and literature review","volume":"16","author":"Jianyong","year":"2025","journal-title":"Discov Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e37093","DOI":"10.1097\/MD.0000000000037093","article-title":"Association between types of abdominopelvic cancer in patients with situs inversus total: Systematic review","volume":"103","author":"Valenzuela-Fuenzalida","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.4290","article-title":"A case of renal cell carcinoma in a patient with situs inversus: Operative considerations and a review of the literature","volume":"11","author":"Oake","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/ol.2024.14296","article-title":"Indolent growth of low-grade myofibroblastic sarcoma of the knee with the resemblance of a benign lesion: A case report","volume":"27","author":"Cheng","year":"2024","journal-title":"Oncol Lett"},{"key":"B11","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1186\/s12891-020-03857-3","article-title":"Low-grade myofibroblastic sarcoma of the levator scapulae muscle: a case report and literature review","volume":"21","author":"Yonezawa","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190210","article-title":"Case Report: Immunotherapy for low-grade myofibroblastic sarcoma of the pharynx","volume":"14","author":"Sun","year":"2023","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21037\/gs-24-347","article-title":"Enhanced magnetic resonance imaging features and management principles of low-grade myofibroblastic sarcoma of the breast: a case report","volume":"14","author":"Zhu","year":"2025","journal-title":"Gland Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1577068","article-title":"Case Report: First case of low-grade myofibroblastic sarcoma of the vulva during pregnancy","volume":"15","author":"Zhu","year":"2025","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-023-01577-3","article-title":"Low-grade myofibroblastic sarcoma of the oral and maxillofacial region: an international clinicopathologic study of 13 cases and literature review","volume":"17","author":"Giraldo-Roldan","year":"2023","journal-title":"Head Neck Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12880-018-0287-z","article-title":"Low-grade Myofibroblastic sarcoma: clinical and imaging findings","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Med Imaging"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26052049","article-title":"Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (Review of literature)","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.87","article-title":"Small-cell lung cancer: what we know, what we need to know and the path forward","volume":"17","author":"Gazdar","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.esmoop.2021.100059","article-title":"Small-cell lung cancer in never-smokers","volume":"6","author":"Torres-Dur\u00e1n","year":"2021","journal-title":"ESMO Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41598-017-01571-0","article-title":"Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1477-7819-9-109","article-title":"Double primary Malignancies associated with colon cancer in patients with situs inversus totalis: two case reports","volume":"9","author":"Kim","year":"2011","journal-title":"World J Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-018-0926-x","article-title":"Video-assisted thoracoscopic bisegmentectomies for double primary lung cancers in a patient with situs inversus totalis","volume":"66","author":"Matsui","year":"2018","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1320679","article-title":"Radical radiation therapy for esophageal carcinoma in situs inversus totalis with the history of surgery for lung cancer: a case report","volume":"15","author":"Chen","year":"2025","journal-title":"Front Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12331","article-title":"Laparoscopic distal gastrectomy for synchronous gastric cancer and gastrointestinal stromal tumor with situs inversus totalis","volume":"35","author":"Namikawa","year":"2021","journal-title":"In Vivo"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2019.05.009","article-title":"Using the common terminology criteria for adverse events (CTCAE - version 5.0) to evaluate the severity of adverse events of anticancer therapies","volume":"112","author":"Freites-Martinez","year":"2021","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"B31","article-title":"A sarcoma of myofibroblasts: an ultrastructural study","volume":"102","author":"Vasudev","year":"1978","journal-title":"Arch Pathol Lab Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199810000-00008","article-title":"Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors","volume":"22","author":"Mentzel","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200102000-00010","article-title":"Myofibrosarcoma: a clinicopathologic study","volume":"25","author":"Montgomery","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.13107\/jocr.2025.v15.i01.5126","article-title":"Low-grade myofibroblastic sarcoma of the acetabulum - A rare case with review of literature","volume":"15","author":"Kumar","year":"2025","journal-title":"J Orthop Case Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12891-025-08565-4","article-title":"Early diagnosis and treatment of low-grade myofibroblastic sarcoma in the left distal femur: a case report and literature review","volume":"26","author":"Hu","year":"2025","journal-title":"BMC Musculoskelet Disord"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4103\/IJPM.IJPM_99_18","article-title":"Low-grade myofibroblastic sarcoma of maxillary sinus and buccal mucosa: Two rare cases and review of the literature","volume":"62","author":"Ghosh","year":"2019","journal-title":"Indian J Pathol Microbiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12957-021-02454-5","article-title":"Surgical treatment and long-term outcomes of low-grade myofibroblastic sarcoma: a single-center case series of 15 patients","volume":"19","author":"Kim","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v15.i4.566","article-title":"Low-grade myofibrosarcoma of the maxillary sinus: Two case reports","volume":"15","author":"Mydlak","year":"2024","journal-title":"World J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.113387","article-title":"Low-grade myofibroblastic sarcoma of the larynx: a rare entity with review of literature","volume":"9","author":"Khosla","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1177\/0145561319840140","article-title":"Management of low-grade myofibroblastic sarcoma of the larynx","volume":"99","author":"Bai","year":"2020","journal-title":"Ear Nose Throat J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3171\/2010.5.PEDS09289","article-title":"Low-grade myofibroblastic sarcoma of the sacrum","volume":"6","author":"Humphries","year":"2010","journal-title":"J Neurosurg Pediatr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-020-02428-7","article-title":"Is there a role for chemotherapy and radiation in the treatment of patients with low-grade myofibroblastic sarcoma","volume":"23","author":"Xu","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-004-0500-0","article-title":"Laparoscopic surgery in situs inversus: a literature review and a report of laparoscopic sigmoidectomy for diverticulitis in situs inversus","volume":"389","author":"Kobus","year":"2004","journal-title":"Langenbecks Arch Surg"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21785","article-title":"Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.924853","article-title":"First-line treatment for advanced SCLC: what is left behind and beyond chemoimmunotherapy","volume":"9","author":"Giunta","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01055","article-title":"Updated overall survival and PD-L1 subgroup analysis of patients with extensive-stage small-cell lung cancer treated with atezolizumab, carboplatin, and etoposide (IMpower133)","volume":"39","author":"Liu","year":"2021","journal-title":"J Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"100408","DOI":"10.1016\/j.esmoop.2022.100408","article-title":"Durvalumab, with or without tremelimumab, plus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer: 3-year overall survival update from CASPIAN","volume":"7","author":"Paz-Ares","year":"2022","journal-title":"ESMO Open"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00224-8","article-title":"Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"23","author":"Wang","year":"2022","journal-title":"Lancet Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03132-1","article-title":"Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial","volume":"30","author":"Cheng","year":"2024","journal-title":"Nat Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00793","article-title":"Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study","volume":"38","author":"Rudin","year":"2020","journal-title":"J Clin Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02212","article-title":"Nivolumab and ipilimumab as maintenance therapy in extensive-disease small-cell lung cancer: checkMate 451","volume":"39","author":"Owonikoko","year":"2021","journal-title":"J Clin Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2024.03.008","article-title":"Tislelizumab plus platinum and etoposide versus placebo plus platinum and etoposide as first-line treatment for extensive-stage SCLC (RATIONALE-312): A multicenter, double-blind, placebo-controlled, randomized, phase 3 clinical trial","volume":"19","author":"Cheng","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.16464","article-title":"Effect of first-line serplulimab vs placebo added to chemotherapy on survival in patients with extensive-stage small cell lung cancer: the ASTRUM-005 randomized clinical trial","volume":"328","author":"Cheng","year":"2022","journal-title":"JAMA"},{"key":"B55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1001\/jamaoncol.2024.5019","article-title":"Toripalimab plus chemotherapy as a first-line therapy for extensive-stage small cell lung cancer: the phase 3 EXTENTORCH randomized clinical trial","volume":"11","author":"Cheng","year":"2025","journal-title":"JAMA Oncol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad342","article-title":"Atezolizumab plus carboplatin and etoposide in patients with untreated extensive-stage small-cell lung cancer: interim results of the MAURIS phase IIIb trial","volume":"29","author":"Bria","year":"2024","journal-title":"Oncologist"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: A review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2020.02.009","article-title":"Radiation therapy for small cell lung cancer: an ASTRO clinical practice guideline","volume":"10","author":"Simone","year":"2020","journal-title":"Pract Radiat Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1782502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T05:26:30Z","timestamp":1773379590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1782502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":58,"alternative-id":["10.3389\/fonc.2026.1782502"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1782502","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"article-number":"1782502"}}